Syndax Pharmaceuticals, Inc. (SNDX)
8.75
-0.38
(-4.16%)
USD |
NASDAQ |
Nov 20, 15:43
Syndax Pharmaceuticals 30-Day Average Daily Volume : 3.693M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 3.693M |
| November 18, 2026 | 3.654M |
| November 17, 2026 | 3.591M |
| November 16, 2026 | 3.543M |
| November 13, 2026 | 3.509M |
| November 12, 2026 | 3.488M |
| November 11, 2026 | 3.442M |
| November 10, 2026 | 3.354M |
| November 09, 2026 | 3.306M |
| November 06, 2026 | 3.242M |
| November 05, 2026 | 3.147M |
| November 04, 2026 | 3.023M |
| November 03, 2026 | 2.591M |
| November 02, 2026 | 2.481M |
| October 30, 2026 | 2.445M |
| October 29, 2026 | 2.533M |
| October 28, 2026 | 2.457M |
| October 27, 2026 | 2.443M |
| October 26, 2026 | 2.390M |
| October 23, 2026 | 2.363M |
| October 22, 2026 | 2.262M |
| October 21, 2026 | 2.239M |
| October 20, 2026 | 2.194M |
| October 19, 2026 | 2.103M |
| October 16, 2026 | 2.076M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.045M |
| October 14, 2026 | 2.025M |
| October 13, 2026 | 1.970M |
| October 12, 2026 | 1.790M |
| October 09, 2026 | 1.757M |
| October 08, 2026 | 1.730M |
| October 07, 2026 | 1.685M |
| October 06, 2026 | 1.665M |
| October 05, 2026 | 1.675M |
| October 02, 2026 | 1.683M |
| October 01, 2026 | 1.635M |
| September 30, 2026 | 1.627M |
| September 29, 2026 | 1.603M |
| September 28, 2026 | 1.589M |
| September 25, 2026 | 1.579M |
| September 24, 2026 | 1.574M |
| September 23, 2026 | 1.541M |
| September 22, 2026 | 1.498M |
| September 21, 2026 | 1.476M |
| September 18, 2026 | 1.447M |
| September 17, 2026 | 1.324M |
| September 16, 2026 | 1.364M |
| September 15, 2026 | 1.354M |
| September 14, 2026 | 1.370M |
| September 11, 2026 | 1.371M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.367M |
| Emergent BioSolutions, Inc. | 1.031M |
| Incyte Corp. | 1.727M |
| Vertex Pharmaceuticals, Inc. | 1.518M |
| Travere Therapeutics, Inc. | 2.007M |